Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group
Key Highlights
- ➤Cuprina (CUPR) to acquire 100% of seven Singapore healthcare clinics for approximately S$4.0 million
- ➤Target Group FY2025 revenue S$9.1 million and normalized EBITDA S$1.2 million
- ➤Consideration includes S$3.0 million cash and S$1.0 million in locked-up shares
- ➤Transaction expected to close on or before November 1, 2026
Expert Statements
David Quek Yong Qi, Chief Executive Officer of Cuprina Holdings (Cayman) Limited
“This acquisition marks a pivotal step in Cuprina’s evolution from a biomedical innovator into a fully integrated healthcare platform”
David Quek Yong Qi, Chief Executive Officer of Cuprina Holdings (Cayman) Limited
“By taking full ownership of ECPC and OCM, we are acquiring high-quality clinical businesses with loyal patient bases, proven management teams, and direct synergies with our core wound-care and collagen technologies, and we retain the entirety of their earnings and the freedom to integrate them completely.”
David Quek Yong Qi, Chief Executive Officer of Cuprina Holdings (Cayman) Limited
“We are building something differentiated: a company where biomedical innovation and frontline clinical delivery reinforce each other.”
1. Acquiring 100% of East Coast Podiatry (five clinics) and Orchard Clinic (two clinics) for approximately S$4.0 million (approximately US$3.1 million) 2. Target Group generated FY2025 unaudited revenue of approximately S$9.1 million and unaudited normalized EBITDA of approximately S$1.2 million, based on unaudited management accounts 3. Sellers’ consideration shares subject to a lock-up 4. Adds an established clinical platform directly aligned with Cuprina’s wound-care and collagen technologies SINGAPORE, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or the “Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that it has entered into Sale and Purchase Agreements (the “SPAs”) to acquire the entire issued and paid-up share capital of (i) East Coast Podiatry Centre Pte. Ltd. (“ECPC”), which operates East Coast Podiatry Clinic (“ECP”), the leading podiatry-focused chain in Singapore; and (ii) Orchard Clinic Management Pte. Ltd. (“OCM”), which operates Orchard Clinic (“ORC”), a Singapore women’s health and wellness clinic (ECPC and OCM together, the “Target Group”), through its direct wholly-owned subsidiary, Cuprina Holdings (BVI) Limited.
Get started
Create a free account to read the full story.